Last reviewed 2026-04-23 · How we verify

MOB015B vehicle

MOB015B is a topical vehicle formulation designed to enhance drug delivery and penetration through the skin barrier.

MOB015B is a topical vehicle formulation designed to enhance drug delivery and penetration through the skin barrier. Used for Topical drug delivery enhancement (specific indication dependent on active ingredient).

At a glance

Mechanism of action

MOB015B vehicle is a pharmaceutical formulation component developed by Moberg Pharma to optimize transdermal or topical drug delivery. As a vehicle, it functions as an inert carrier system that improves the bioavailability and skin penetration of active pharmaceutical ingredients, potentially enhancing therapeutic efficacy of topically applied medications.

Approved indications

• Topical drug delivery enhancement (specific indication dependent on active ingredient)

Common side effects

No common side effects on file.

Key clinical trials

• A Vehicle-controlled Study of Topical MOB015B in the Treatment of Distal Subungual Onychomycosis (DSO) (PHASE3)
• Study to Evaluate the Sensitizing Potential of MOB015B in Healthy Subjects Using a Repeat Insult Patch Test Design (PHASE1)
• Skin Irritation Potential of MOB015B in Healthy Subjects Using a Cumulative Irritant Patch Test Design (PHASE1)
• A Multi-centre, Double-blind, Randomized, Vehicle-controlled Study of Efficacy and Safety of Topical MOB015B in the Treatment of Mild to Moderate Distal Subungual Onychomycosis (DSO) (PHASE3)

Primary sources

Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.

Competitive intelligence

For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:

• MOB015B vehicle CI brief — competitive landscape report
• MOB015B vehicle updates RSS · CI watch RSS
• Moberg Pharma AB portfolio CI